A Study of ABBV-927, an Immunotherapy, in Participants With Advanced Solid Tumors

Condition:   Advance Solid Tumors
Interventions:   Drug: ABBV-927;   Drug: ABBV-927;   Drug: Nivolumab
Sponsor:   AbbVie
Not yet recruiting - verified November 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2hlOpfz
via IFTTT